PROF. JOSEPH KATTAN
Head of the Hematology-Oncology Department
Faculty of Medicine Saint Joseph University, Lebanon
Pr. Joseph Kattan is currently the Head of the Hematology-Oncology Department at The Faculty of Medicine, Saint-Joseph University, Lebanon and the former Head of the Hematology-Oncology Department at Hôtel-Dieu de France University Hospital (HDF), Lebanon from 2014 till 2022. He is a full professor, the president of the Continuous Medical Education oce (CME) at Saint Joseph University-Faculty of medicine, and the secretary of the Cancer Research Group (CRG) in Lebanon. He is also responsible for many courses and programs in this eld at Saint Joseph University, Lebanon and previously at Paris XI University, France. He is the founder of the teaching tool of “learning by debate” and of the “FRON” (the regional research competition in oncology). Pr. Kattan was formerly the Head of Hematology- Oncology Department of the Saint Joseph Hospital- Raymond and Aida Najjar Medical Center, Lebanon from 1994 till 2014. He is the author of more than 350 peer reviewed articles in many international journals focusing on pharmacology, drug development, genito-urinary, gastro-intestinal oncology, gynecology, intensied therapy, supportive and palliative care. Pr. Kattan earned his Medical Degree in 1986, and then started his ve-year training in 1988 at Gustave-Roussy Institute, France. After which, He completed his specializations in Oncology (1989), Immunology (1991), and in Hematology (1993) from the University of Paris XI, France. Pr. Kattan is a member of many national and international societies (American Society of Clinical Oncology, European Society of Medical Oncology, Multinational Association of supporting care in Cancer, French Cancer Society, European Hematology Association, International society of Geriatric Oncology and Lebanese Society of Medical Oncology) and a principal investigator in numerous regional and multinational clinical trials. He is also a current or former member of the editorial board of many journals (Bulletin du Cancer, Cancer Letter, International Journal of Hematology and Oncology and the Lebanese Medical Journal).
Head of the Hematology-Oncology Department
Faculty of Medicine Saint Joseph University, Lebanon
Pr. Joseph Kattan is currently the Head of the Hematology-Oncology Department at The Faculty of Medicine, Saint-Joseph University, Lebanon and the former Head of the Hematology-Oncology Department at Hôtel-Dieu de France University Hospital (HDF), Lebanon from 2014 till 2022. He is a full professor, the president of the Continuous Medical Education oce (CME) at Saint Joseph University-Faculty of medicine, and the secretary of the Cancer Research Group (CRG) in Lebanon. He is also responsible for many courses and programs in this eld at Saint Joseph University, Lebanon and previously at Paris XI University, France. He is the founder of the teaching tool of “learning by debate” and of the “FRON” (the regional research competition in oncology). Pr. Kattan was formerly the Head of Hematology- Oncology Department of the Saint Joseph Hospital- Raymond and Aida Najjar Medical Center, Lebanon from 1994 till 2014. He is the author of more than 350 peer reviewed articles in many international journals focusing on pharmacology, drug development, genito-urinary, gastro-intestinal oncology, gynecology, intensied therapy, supportive and palliative care. Pr. Kattan earned his Medical Degree in 1986, and then started his ve-year training in 1988 at Gustave-Roussy Institute, France. After which, He completed his specializations in Oncology (1989), Immunology (1991), and in Hematology (1993) from the University of Paris XI, France. Pr. Kattan is a member of many national and international societies (American Society of Clinical Oncology, European Society of Medical Oncology, Multinational Association of supporting care in Cancer, French Cancer Society, European Hematology Association, International society of Geriatric Oncology and Lebanese Society of Medical Oncology) and a principal investigator in numerous regional and multinational clinical trials. He is also a current or former member of the editorial board of many journals (Bulletin du Cancer, Cancer Letter, International Journal of Hematology and Oncology and the Lebanese Medical Journal).